Medication info

Myungmoon Pitavastatin Tablets 2mg (Pitavastatin Calcium)

Prescription medicationTabletOralExpired
Ingredient · strength
Pitavastatin Calcium›2mg / 1 tablet
Manufacturer / importer
Myungmoon Pharmaceutical Co., Ltd.
Appearance
Round film-coated tablet with a very light yellow-red color and a score line
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 202009440 · Approved 2020.12.31

This product's status changed to Expired on 2025.12.31. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium per dose, taken once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased up to a maximum of 4 milligrams daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goals, and patient response; the therapeutic effect of this medicine is maintained with continued administration.

Ingredients

Manufacturer
Myungmoon Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • dyslipidemia
View approved original text

This medicine helps lower high total cholesterol, LDL-cholesterol, Apo-B protein, and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia. It also increases HDL-cholesterol levels, known as good cholesterol, improving lipid balance in the blood. This treatment is used in conjunction with diet and plays an important role in preventing cardiovascular diseases. Therefore, this drug effectively regulates cholesterol and lipid levels to help maintain healthy blood vessels.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium per dose, taken once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased up to a maximum of 4 milligrams daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goals, and patient response; the therapeutic effect of this medicine is maintained with continued administration.

Precautions

This drug is used to lower cholesterol levels and should not be used in certain patients. For example, it should not be administered to patients allergic to any components of this medication, those with severe liver dysfunction, patients with myopathy, pregnant or breastfeeding women, and children. Additionally, patients with renal dysfunction, a history of liver disease, excessive alcohol consumption, elderly patients, and those with hypothyroidism should use this drug with caution. In particular, the risk of side effects such as muscle damage or renal function deterioration may increase when taken with other drugs, so it is essential to consult a physician or pharmacist. During treatment with this drug, unusual symptoms such as muscle pain, weakness, abdominal pain, rash, and itching may occur, and if these symptoms arise, medical personnel must be notified immediately. Regular liver function tests and blood tests should be conducted, and if any abnormalities are found, treatment may be discontinued. This drug should not be administered to pregnant women or those who may become pregnant, nor to breastfeeding women, and its safety has not been confirmed in children. Care should be taken regarding drug interactions, especially with concomitant use of cyclosporine, fibrate drugs, niacin, and erythromycin, as serious side effects can occur, so co-administration should be avoided. When taking this drug, diet and exercise therapy should be combined, and regular blood lipid level tests should be performed to verify treatment effectiveness. In elderly patients, the risk of side effects may be higher, so dose adjustment and caution are necessary. Finally, this drug should be kept out of reach of children, and it should not be stored in a different container than its original packaging.

Side effects

  • Abdominal pain
  • rash
  • malaise
  • paralysis
  • itching
  • myalgia
  • weakness
  • elevated CPK levels
  • increased myoglobin in blood and urine
  • acute renal failure
Show 82 more
  • liver dysfunction
  • jaundice
  • thrombocytopenia
  • urticaria
  • erythema
  • angioedema
  • elevated bilirubin
  • increased cholinesterase
  • elevated AST
  • elevated ALT
  • elevated γ-GT
  • elevated ALP
  • elevated LDH
  • rigidity
  • drowsiness
  • insomnia
  • headache
  • heavy head sensation
  • dizziness
  • thirst
  • dyspepsia
  • abdominal distension
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • gastric discomfort
  • diarrhea
  • granulocytopenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • elevated globulin
  • positive Coombs test
  • anemia
  • frequent urination
  • elevated BUN
  • elevated serum creatinine
  • decreased aldosterone
  • increased aldosterone
  • elevated adrenocorticotropic hormone
  • increased cortisol
  • decreased testosterone
  • muscle cramps
  • loss of strength
  • palpitations
  • fatigue
  • skin pain
  • burning sensation
  • arthralgia
  • edema
  • blurred vision
  • photophobia
  • hearing loss
  • hematuria
  • elevated uric acid levels
  • increased serum potassium and phosphorus
  • altered taste
  • positive antinuclear antibodies
  • sleep disturbances
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes
  • immune-mediated necrotizing myopathy
  • myasthenia gravis
  • ocular myasthenia
  • facial edema
  • arm edema
  • hypersensitivity
  • headache
  • dizziness
  • paresthesia
  • insomnia
  • loss of appetite
  • elevated blood pressure
  • chest discomfort
  • weakness
  • nausea

Not everyone experiences these, and they can vary from person to person.

Storage

This drug may be sensitive to light, so it should be stored in a container that does not allow light to enter. Additionally, it should be kept at a cool room temperature, ideally between 1 degree and 30 degrees.

Appearance and packaging

Appearance

Round film-coated tablet with a very light yellow-red color and a score line

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.